Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

March 29, 2015 2:23 AM ET


Company Overview of Nimbus Therapeutics, Inc.

Executive Profile

Daniel S. Lynch M.B.A

Chief Executive Officer, President and Director, Ivrea Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 10 Board Members in 10 different organizations across 14 different industries.

See Board Relationships


Mr. Daniel S. Lynch, also known as Dan, M.B.A has been the President and Chief Executive Officer of IVREA Pharmaceuticals Inc. since February 1, 2007. Mr. Lynch has been a Venture Partner at Third Rock Ventures, LLC since May 14, 2013. He supports the commercial and business development of existing portfolio companies and serves as a strategic advisor across the portfolio. He was an Entrepreneur-in-Residence of Third Rock Ventures, LLC from joining in May 2011 to May ...

Corporate Headquarters

25 First Street
Cambridge, Massachusetts 02141

United States

Phone: 617-588-2655
Fax: 617-231-0652

Board Members Memberships

Chief Executive Officer, President and Director
Executive Chairman
Former Director
Member of The Board of Directors
Chief Executive Officer, Chief Administrative Officer, Senior Vice President and Member of Board of Directors
Director, Member of Audit Committee and Director of US Oncology Inc
Director, Member of Audit Committee and Director of US Oncology Inc
Chairman, Chairman of Compensation Committee and Member of Audit Committee
Executive Chairman
Executive Chairman
Chairman, Chairman of Compensation Committee, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee


Wesleyan University
Colgate W. Darden Graduate School of Business Administration

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Nimbus Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at